New insights into role of microenvironment in multiple myeloma

Lancet. 2000 Jan 22;355(9200):248-50. doi: 10.1016/S0140-6736(00)00019-2.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Carrier Proteins / metabolism
  • Cytokines / metabolism
  • Diphosphonates / therapeutic use
  • Glycoproteins / metabolism
  • Humans
  • Membrane Glycoproteins / metabolism
  • Multiple Myeloma* / drug therapy
  • Multiple Myeloma* / immunology
  • Multiple Myeloma* / pathology
  • Osteoprotegerin
  • Pamidronate
  • RANK Ligand
  • Receptor Activator of Nuclear Factor-kappa B
  • Receptors, Cytoplasmic and Nuclear*
  • Receptors, Tumor Necrosis Factor / metabolism

Substances

  • Antineoplastic Agents
  • Carrier Proteins
  • Cytokines
  • Diphosphonates
  • Glycoproteins
  • Membrane Glycoproteins
  • Osteoprotegerin
  • RANK Ligand
  • Receptor Activator of Nuclear Factor-kappa B
  • Receptors, Cytoplasmic and Nuclear
  • Receptors, Tumor Necrosis Factor
  • TNFRSF11A protein, human
  • TNFRSF11B protein, human
  • TNFSF11 protein, human
  • Pamidronate